Johnson & Johnson proposed a settlement plan to settle all the thousands of lawsuits it faces in the U.S. The company is accused of selling talc-based products that could cause ovarian cancer.

Johnson & Johnson has made a significant acquisition, purchasing medical device maker Shockwave Medical for approximately $13.1 billion to strengthen the company's efforts in fighting heart disease.

Nvidia has partnered with Johnson & Johnson to develop new AI applications to help doctors perform surgery.

It's no longer unusual if you see working mothers in the office, streets, or restaurants. With the high cost of living, children's education, and bills to pay, couples should help each other to make both ends meet.

With an objective of taking additive manufacturing (3-D printing) to further advance level, America Makes has drawn up plans to support research and development (R&D) with financial funding of up to $8 million.

International Business Machines Corp, deepening its partnership with Apple Inc to make use of health information gathered by millions of Apple devices, is creating a unit dedicated to providing data analytics to the healthcare sector.

Belgian biotech group Galapagos said on Tuesday that its research partner Janssen Pharmaceutica, a unit of Johnson & Johnson, had pulled out of a program to develop a new drug to treat bowel disease.

U.S. medical device maker Medtronic (MDT.N) gained European Union regulatory approval on Friday for its $43 billion takeover of Covidien Plc (COV.N) after agreeing to sell its Irish rival's drug-coated balloon catheter business.

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.